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1. Introduction 
Conventional echocardiography is widely used and well documented in evaluation of 
patients with stable and unstable coronary artery disease (Mollema et al., 2009). In 
particular, assessment of left ventricular function, volumes and ejection fraction adds 
important prognostic information in individual patients. In addition, echocardiography may 
detect any concomitant valvular heart disease as well as acute complications in unstable 
coronary syndromes.  Stress echocardiography has through several studies established its 
role in diagnosis of stable coronary artery disease and assessment of myocardial viability 
(Sicari et al., 2008). 
However, introduction of ultrasound contrast agents and contrast specific imaging 
modalities have significantly improved the usefulness of echocardiography in diagnosis and 
assessment of coronary artery disease (Dijkmans et al., 2006). Indications for use of 
ultrasound contrast are implemented in guidelines for assessment of left ventricular 
function at rest and during stress echocardiography (Senior et al., 2009; Mulvagh et al., 
2008). Ultrasound contrast is recommended for assessing left ventricular ejection fraction at 
rest when image quality is suboptimal and for stress echocardiography when the 
endocardial boarder is not visualized in 2 or more left ventricular segments (Senior et al., 
2009; Mulvagh et al., 2008).  
In contrast echocardiography regional myocardial function and perfusion may be assessed 
simultaneously, thereby optimizing the non-invasive diagnostics of coronary artery disease. 
The incremental value of assessing myocardial perfusion in diagnosing coronary artery 
disease is emphasised by the ischemic cascade (Fig. 1), demonstrating that hypoperfusion 
precedes functional impairment, ECG changes, symptoms and myocardial necrosis as 
depicted in Fig.1. (Crossman, 2004; Leong-Poi et al., 2002).  
Diagnosing distribution and extent of myocardial ischemia by contrast echocardiography 
can give information on the total ischemic burden and has become a supplemental tool in 
evaluation of the physiological impact of an angiographic coronary artery stenosis. 
Consequently, myocardial perfusion assessment by contrast echocardiography may also be 
used for risk prediction in patients with known coronary artery disease and in prioritizing 
the need for urgent revascularization among patients with acute coronary syndromes 
(Jeetley et al., 2007; Rinkevich et al., 2005; Lønnebakken  et al., 2011). It has the potential to 
become a future tool to tailor and evaluate the effect of treatment on myocardial perfusion 
in patients with different clinical syndromes of coronary artery disease. Furthermore, 
www.intechopen.com
Coronary Angiography 
 – Advances in Noninvasive Imaging Approach for Evaluation of Coronary Artery Disease 
 
62
contrast echocardiography can be used to identify myocardial ischemia in patients with 
non-obstructive coronary artery disease i.e. microvascular disease which cannot be 
diagnosed by routine coronary angiography.   
 
Ischemia
Time
Hypoperfusion
Metabolic disturbances
Diastolic dysfunction
Systolic dysfunction
ECG changes
Myocardial necrosis
Chest pain
 
Fig. 1. The ischemic cascade 
2. Methodology 
Contrast echocardiography has several advantages compared to other non-invasive imaging 
techniques like cardiac magnetic resonance imaging and cardiac computer tomography. 
First, it can be performed without the radiation exposure of computer tomography and 
without the potential nephrotoxisity of the gadolinium contrast agent necessary to assess 
myocardial perfusion by magnetic resonance imaging. Second, it can be performed bed-side 
and give immediate answers to important clinical questions in management of patients with 
known or suspected coronary artery disease. Contrast echocardiography requires 
intravenous administration of a second or third generation ultrasound contrast agent during 
contrast specific ultrasound imaging.  
2.1 Ultrasound contrast agents and imaging modalities 
Ultrasound contrast agents consist of microbubbles with an inert gas core surrounded by a 
shell. Due to the microbubble size and stability, they can pass the pulmonary circulation 
without destruction and intravenous administration as bolus dosages or continuous 
infusion can therefore be used (Senior et al., 2009). Importantly, the contrast microbubbles 
act as isolated intravascular tracers and are therefore ideal for perfusion assessment.  Future 
possibility of targeting contrast microbubbles against specific disease processes, including 
inflammation in unstable plaque, activated platelets in thrombus formation or against 
factors involved in angiogenesis may allow even more specific diagnoses (Kaufman & 
Lindner., 2007; Chadderdon & Kaul., 2010). 
Ultrasound contrast agents in coronary artery disease have been shown to be safe, but 
allergic anaphylactic reactions have been observed (Senior et al., 2009; Wei et al., 2008). 
Therefore, patients should be observed closely with continuous recording of heart rhythm 
and frequent measurement of blood pressure during contrast echocardiography and for at 
least 20 minutes after the examination. Emergency equipment should always be available in 
the examination room during contrast echocardiography. Contrast echocardiography has 
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few absolute contraindications, except for known allergy against the contrast agent. 
However, caution and close observation should be performed in patients with unstable 
coronary artery disease or decompensated heart failure. Ultrasound contrast agent should 
also be used with caution in patients with severe pulmonary disease. The gas in the contrast 
microbubbles is excreted through the lungs, and in patients with severe pulmonary disease, 
clearance is delayed, causing increased halftime of the gas in the circulation. In patients with 
mechanical valve prosthesis contrast echocardiography should be avoided due to extensive 
destruction of contrast microbubbles by the prosthesis. An overview of current 
commercially available ultrasound contrast agents is given in Table 1. 
 
Contrast agents Gas core Shell 
SonoVue Sulphur hexafluoride Phospholipid monolayer 
Luminity/Definity Perflutren Phospholipid monolayer 
Optison Perflutren Albumin 
Albunex Air Albumin 
Table 1. Gas core and shell composition in ultrasound contrast agents available for clinical 
use 
Contrast microbubbles have unique acoustic properties when exposed to ultrasound. At very 
low mechanical index, the ultrasound microbubbles have a linear response to the ultrasound 
exposure. At low mechanical index (MI 0.08-0.3) the ultrasound microbubbles start to oscillate 
giving rise to a non-linear response contrasting the linear response of the myocardial tissue at 
low mechanical index. Contrast specific ultrasound imaging modalities remove the linear 
tissue response and enhance the contrast microbubble response. Different techniques may be 
used to emphasis the contrast microbubbles acoustic signals and to filter the tissue signals, the 
main techniques being power modulation, pulse inversion or coherent contrast imaging. 
Low-mechanical index imaging is the most commonly used modality, often combined with 
a high energy ultrasound flash causing microbubble destruction, known as destruction-
replenishment imaging or flash imaging (Fig. 2). By this technique real-time contrast 
echocardiography with simultaneous assessment of myocardial function and perfusion can 
be performed.   
High mechanical index imaging causes microbubble destruction. By high mechanical index 
triggered imaging, myocardial perfusion can be assessed, but myocardial function can not 
be assessed simultaneously using this imaging modality. The advantage of this imaging 
modality is a better reproducibility for quantification of myocardial perfusion. 
2.2 Performance and image interpretation 
Ultrasound contrast may be used to improve endocardial border delineation, a technique 
known as left ventricular opacification (LVO) (Fig.3) (Chahal & Senior, 2010), which has 
been demonstrated to optimize assessment of left ventricular volumes and ejection fraction 
by echocardiography compared to cardiac magnetic resonance imaging, the current gold 
standard (Malm et al., 2006). In patients with poor acoustic windows, left ventricular 
ejection fraction is often underestimated if ultrasound contrast is not used (Kurt et al., 2009; 
Plana et al., 2008). Using ultrasound contrast significantly improves echocardiographic 
reproducibility and accuracy in patients with poor acoustic windows, and use of contrast 
echocardiography in such cases for accurate assessment of left ventricular ejection fraction is  
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Low mechanical index imaging with destruction
replenishment
Initial high energy ultrasound burst Low energy ultrasound imaging
(10 heart cyclies)
Contrast microbubble destruction
Allowing assessment of refilling
Contrast microbubble oscillation
Contrast specific ultrasound signals
 
Fig. 2. Destruction replenishment contrast echocardiography, where a high energy 
ultrasound burst causes ultrasound microbubble destruction, followed by low mechanical 
index ultrasound imaging assessing only the non-linear ultrasound refection from 
oscillating contrast microbubbles by contrast specific ultrasound imaging allowing 
assessment of contrast enhancement and hence myocardial perfusion.   
recommended in current guidelines (Senior et al., 2009). Similarly, during stress 
echocardiography, adding ultrasound contrast allows a complete evaluation of wall motion 
in all myocardial regions in almost every patient (Hoffmann et al., 2007).  
In a study of 632 patients with poor acoustic windows, adding ultrasound contrast not only 
avoided the need of further expensive and time consuming examinations but also had direct 
impact on patient’s treatment (Kurt et al., 2009). 
 
 
Fig. 3. Left ventricular opacification (LVO) by contrast echocardiography illustrating the 
improved endocardial border delineation in particular in the apical part of the left ventricle 
in an apical 4-chamber view compared to conventional echocardiography. 
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In myocardial contrast echocardiography (MCE), contrast is not only used for enhanced 
endocardial border delineation, but also for assessment of regional perfusion with high 
spatial and temporal resolution (Fig. 4) (Elhendy & Porter., 2005). MCE has the potential to 
significantly improve non-invasive evaluation of coronary artery disease (Elhendy et al., 
2004; Lønnebakken et al., 2009). Contrasting other non-invasive imaging modalities, MCE 
visualizes the capillary filling in the myocardium and can give information on regional 
myocardial perfusion including subendocardial hypoperfusion, which is the first sign of 
ischemia (Dijkmans et al.,2006). Consequently, MCE increases the sensitivity to detect 
ischemia. In addition, myocardial microvascular integrity can be evaluated and myocardial 
viability assessed. 
Myocardial contrast echocardiography is mainly performed using apical 4-chamber, apical 
2-chamber and apical 3-chamber views. Parasternal imaging is more difficult due to contrast 
attenuation, but additional parasternal long- and short axis images may be useful in 
individual patients, in particular at peak stress. By combining rest-imaging with an exercise 
or pharmacological stress test, myocardial function and perfusion can be evaluated not only 
at rest but also during stress, which is particularly important in diagnosis of stable coronary 
artery disease, evaluation of viability and in evaluating the result after coronary 
revascularization.  Image analysis is performed using a standardized 17-segment left 
ventricular model, in which the different left ventricular segments are assigned to the three 
main coronary arteries using a standardized scheme (Fig. 5) (Lang et al., 2006). However, the 
considerable variation in coronary artery anatomy must be taken into account when 
comparing MCE results to coronary angiography. 
 
 
Fig. 4. Myocardial contrast echocardiography with low mechanical index demonstrating the 
delayed contrast enhancement in the distal septum and apex of the left ventricle (green 
arrows) compared to the proximal septum and lateral wall in an apical 4-chamber view. 
2.2.1 Wall motion scoring 
Myocardial regional function or wall motion is evaluated from active myocardial thickening 
and scored according to current guidelines as normal (1), hypokinetic (2), akinetic (3) or 
dyskinetic (4) (Sicari et al., 2008). In addition, there should be a further increase in wall 
thickening during stress testing to be scored as normal. In viability assessment, an akinetic 
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segment that starts to function at low stress level but ceases to function again at higher stress 
level is indicative of viable myocardium with ischemia, known as the biphasic response, 
typically for stunned or hibernating myocardium. Such findings indicate that the regional 
myocardial function will improve from revascularisation.  Akinetic myocardial segments 
that remain akinetic during stress indicate infarct scarring which will not benefit from 
revascularization. 
 
Panel A Panel B
 
Fig. 5. Left ventricular model for wall motion and perfusion scoring during contrast 
echocardiography and standardized attribution to the main coronary arteries. 
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2.2.2 Perfusion scoring 
Regional perfusion scoring is based on visual evaluation of contrast enhancement in the 
myocardium. At rest the myocardium should be filled with contrast during 5 heart beats, 
while at peak stress the myocardium should be filled in 1-2 heart beats. Delayed 
enhancement is consistent with hypoperfusion or ischemia, while lack of enhancement is 
consistent with myocardial fibrosis of infarct scaring. However, artefacts like contrast 
destruction in the near field may cause false perfusion defects in the apical myocardium, 
while attenuation may cause false perfusion defects in the basal parts. In addition, perfusion 
defects in thin fibrotic myocardium may be underestimated because of shine-through effect.  
In patients with stable coronary artery disease, perfusion scoring by contrast stress 
echocardiography has been demonstrated to identify prognostically important angiographic 
coronary artery disease (multivessel disease and proximal stenosis in the left anterior 
descending artery) significantly better than wall motion scoring (Lønnebakken et al., 2009). 
However, anatomical variations in coronary anatomy as well as collateral circulation and 
coronary artery bypass grafting will influence the perfusion area of the individual coronary 
artery. Therefore, except for stenosis in the proximal left anterior descending artery, the 
anatomic culprit lesion can usually not be identified by MCE.  
2.2.3 Quantification of myocardial perfusion 
Quantification software assessing contrast enhancement from increase in video intensity 
over time has been developed (Agati et al., 2005). From quantitative analysis, typical 
contrast enhancement curves can be obtained for blood flow velocity (β), perfusion rate 
(Axβ), refilling time (rt) and total blood volume (A) (Fig.6.). In normally perfused 
 
A, % 
Time, msec
Normal perfusion
Ischemia
Refilling time (rt)
Axβ
Axβ
Infarct scarring
 
Fig. 6. Contrast enhancement curves: for normally perfused myocardium (red curve), 
ischemic/hypoperfused myocardium and for infarct area (blue curve), respectively. 
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myocardium, the blood flow velocity is about 0.5 ml/s and the peak intensity level is 
rapidly reached (Fig.6 red curve). In ischemic myocardium, both the blood flow velocity and 
perfusion rate are reduced, the refilling time is increased while the total blood volume 
remains normal (Fig.6 green curve). This contrasts the reduced total blood volume 
characterizing the myocardial contrast enhancement in infracts scarring and myocardial 
fibrosis (Fig.6 blue curve) (Wei et al., 1998; Toledo et al., 2006).   
Using quantification, it is theoretically possible to compare myocardial perfusion in different 
regions and settings. However, previous studies have demonstrated that it is difficult to 
compare between different patients due to large interindividual variation. In a study of 20 
healthy subjects with normal wall motion and coronary angiography, both considerable 
inter-individual and also inter-regional variability in perfusion parameters were noted, 
suggesting that quantitative perfusion parameters currently are best suited for with-in 
patient repeated assessment, for instance during stress testing (Malm 2005). This was 
confirmed in a follow-up study of patients who underwent quantitative contrast stress 
echocardiography prior to and 9 months after percutaneous coronary revascularization. In 
this study, stress induced perfusion but not absolute perfusion parameters were improved 
in patients with angiographic successful result, while a lack of improvement in stress 
induced perfusion was associated with angiographically confirmed restenosis irrespective of 
patient symptoms (Lønnebakken et al., 2009). However, standardisation and assessment of 
optimal cut-off values for myocardial perfusion has to be derived from larger trials before 
quantification of myocardial perfusion can be used in clinical assessment of coronary artery 
disease (Abdelmoneim  et al., 2009). 
3. Clinical applications 
Contrast echocardiography has documented important clinical impact on diagnosis, risk 
prediction and follow-up of patients with different clinical syndromes of coronary artery 
disease as well as in detection of thrombotic complications in patients with ischemic heart 
disease. In addition assessing the total ischemic burden and viability by contrast 
echocardiography adds prognostic information in individual patients.  
3.1 Stable coronary artery disease 
Diagnosing stable coronary artery disease may be challenging, in particular since atypical 
symptoms are not uncommon. The most used diagnostic test in coronary artery disease, the 
exercise electrocardiogram, is associated with a low accuracy to detect significant angiographic 
coronary artery disease. Invasive coronary angiography is according to current guidelines the 
diagnostic gold standard. However, it is invasive and associated with potential risk for severe 
complications and allergic reactions, and includes radiation exposure. Furthermore, coronary 
angiography does not give information on the functional importance of a coronary stenosis. 
Stress echocardiography has an overall diagnostic sensitivity of 85% and specificity of 90% in 
detecting significant angiographic coronary artery disease from meta-analyses (Senior et al., 
2005; Picano et al., 2008). However, in 33% of patients referred for conventional stress 
echocardiography the image quality does not allow adequate evaluation. By adding 
ultrasound contrast during stress echocardiography almost all patients can be satisfactory 
examined by stress echocardiography and by simultaneous assessment of both myocardial 
function and perfusion (MCE) the sensitivity of detecting significant angiographic coronary 
artery stenosis may be increased to 90% but the specificity is reduced (Senior et al., 2009). 
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In a meta-analysis of 8 studies the sensitivity and specificity of detecting coronary artery 
disease by myocardial contrast stress echocardiography was 83 and 80 %, respectively.  In 
patients with known or suspected coronary artery disease, perfusion was significantly 
better than wall motion analysis in detecting angiographic coronary artery stenosis, in 
particularly at intermediate stress level (Elhendy et al., 2004). In addition, in patients with 
known coronary artery disease awaiting percutaneous coronary intervention, perfusion 
scoring was significantly better than wall motion scoring in identifying patients with 
prognostic significant angiographic coronary artery stenosis, like triple-vessel disease and 
proximal stenosis in the left anterior descending artery (Lønnebakken et al., 2009). Of note 
this could be achieved at intermediate stress level. Failure to achieve adequate stress level 
is an important limitation in assessing coronary artery disease by stress 
electrocardiography or stress echocardiography. It has been demonstrated that using 
contrast stress echocardiography with perfusion assessment (MCE) seems to overcome 
this limitation.  
The weak association between the degree of angiographic coronary artery stenosis and 
quantitative myocardial perfusion by contrast stress echocardiography has been noted in 
several studies (Malm et al., 2006; Peltier et al., 2004; Perez et al., 2004; Lønnebakken et al., 
2009). This may be explained by the fact that many other factors than coronary artery lumen 
diameter reduction is important for myocardial perfusion, including coronary flow 
autoregulation, collateral circulation, stenosis length and serial stenosis in addition to 
hemodynamic condition are important for myocardial perfusion. Although, mainly due to 
anatomic variation in coronary anatomy, contrast stress echocardiography has limited 
power to predict the anatomical localisation of angiographic coronary artery stenosis, the 
method is accurate to predict proximal stenosis in the left anterior descending coronary 
artery and to identify patients with multivessel disease. In addition, assessing the total 
ischemic burden in the individual patient may be clinical important for choosing the optimal 
treatment. It has been demonstrated that only patients with an ischemic burden >20% will 
benefit prognostically from revascularization, otherwise revascularization will only have 
symptomatic effect, suggesting that asymptomatic or low-symptomatic patients will have 
no or little effect and may be equally well off treated medically.  
3.2 Acute coronary syndrome 
Patients with acute coronary syndrome are a heterogeneous group with varying disease 
severity and prognosis, from unstable angina pectoris, non-ST elevation myocardial 
infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI). It is well known that 
both short- and long-term prognosis in NSTEMI patients is as severe as STEMI patients, 
although the incidence of acute coronary artery occlusions varies. It has been demonstrated 
that contrast echocardiography can be used for risk assessment in acute coronary syndrome 
patients (Senior et al., 2004; Khang et al., 2005).  
3.2.1 Unstable angina pectoris 
In patients hospitalized with acute chest pain but having normal serum troponin level, 
contrast echocardiography has been shown to be a useful tool to distinguish between 
patients with acute coronary syndrome and non-cardiac chest pain (Jeetley et al., 2007; 
Rinkevich et al., 2005; Kaul et al., 2004). Another study in 957 patients with acute chest pain 
and a non-diagnostic electrocardiogram demonstrated that myocardial perfusion by 
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contrast echocardiography was better than other commonly used risk score models like the 
Thrombolysis in Myocardial Infarction (TIMI) risk score (Antman et al., 2000) to 
discriminate between patients with  intermediate or high risk for reinfarction or death (Tong 
et al., 2005). Based on current documentation, advanced echocardiography is underused in 
diagnostics and management of patients with acute chest pain.   
 
Variables in TIMI risk score score 
Age ≥65 years 1 
≥3 risk factors of CAD (family history of CAD, hypertension, diabetes, current 
smoking, hypercholesterolemia) 
1 
Prior CAD (previous MI, CABG, PCI or known angiographic stenosis ≥50%) 1 
ST-segment depression ≥0.05 mV in ≥2 ECG leads 1 
≥2 episodes of chest pain the last 24 hour 1 
Aspirin the last 7 days or unfractionated heparin the last 24 hour 1 
Elevated serum cardiac markers 1 
Table 2. Thrombolysis In Myocardial Infarction risk score (TIMI). 
3.2.2 Non-ST elevation myocardial infarction 
Current guidelines for management of NSTEMI are diverging, recommending invasive risk 
stratification and revascularization within 12-72 hours in patients at intermediate and high 
risk (Bassand et al., 2007; Smith et al., 2006). In clinical risk assessment, TIMI risk score is 
one of the most recommended and widely used models in NSTEMI patients (Table 2). Of 
note, these clinical risk score models may underestimate angiographic coronary artery 
disease severity, in particular in patients scored as intermediate risk (Volat et al., 2008). In a 
recently published series of 110 patients with NSTEMI, the extent of myocardial ischemia 
assessed by contrast echocardiography was a better predictor of angiographic severe 
coronary artery disease than the TIMI risk score, in particular in identifying patients with 
severe disease like left main stem stenosis, trippel-vessel disease or multi-vessel disease 
including proximal stenosis in the left anterior descending artery and also better than wall 
motion scoring analysis (Fig. 7) (Lønnebakken et al., 2011). In another study in NSTEMI 
patients, about 30% of the patients had an acute occlusion of a main coronary artery despite 
normal electrocardiogram. In this study, deformation analysis by echocardiography has 
proven useful in identifying NSTEMI patients with severe angiographic coronary artery 
disease (Grenne et al., 2010). In particular serial assessment of regional left ventricular strain 
may identify these patients while awaiting coronary angiography and revascularisation. 
Theoretically, detection of these patients by either contrast echocardiography or other 
advanced imaging techniques represents new tools for identification of patients with high 
subclinical ischemic burden that may benefit from earlier revascularization.  
3.2.3 ST elevation myocardial infarction 
In acute STEMI the recommended treatment is immediate coronary angiography and 
revascularization. Contrast echocardiography can assess area at risk and help in diagnosing 
acute myocardial infarction in patients with acute chest pain and a non-diagnostic ECG, 
particularly common in patients with acute occlusion of the circumflex artery (Hayat & 
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Senior., 2008). But contrast echocardiography will not be indicated in pre-catheterization 
evaluation of most patients with STEMI.  
 
 
Fig. 7. Contrast echocardiography in apical 4-chamber, 2-chamber and 3-chamber views 
(upper panels) demonstrating the extensive reduction of myocardial perfusion in a NSTEMI 
patient with angiographic trippel-vessel disease including acute occlusion of the right 
coronary artery and left main stem stenosis (lower panels). 
In spite of successful reopening of the infarct related artery by percutaneous coronary 
intervention, some STEMI patients still develop unexpectedly large myocardial infarctions 
due to the no-reflow phenomenon. The no-reflow phenomenon is caused by impaired 
microcirculation which can be a consequence of peripheral embolization during the 
percutaneous revascularization procedure or revascularisation damage due to inflammation 
and oedema causing microvascular obstruction and subsequent myocardial necrosis. The 
no-reflow phenomenon after revascularization can be diagnosed by MCE (Kaul., 2006). Lack 
of reperfusion after coronary intervention predicts myocardial necrosis, reduced left 
ventricular function, left ventricular remodelling and subsequent development of heart 
failure. Thus, MCE may be used in STEMI patients to identify successful reopening of the 
infarct related artery and to give prognostic information by identifying patients with no-
reflow who need additional treatment in the acute and chronic phase of a STEMI (Dwivedi 
et al., 2008; Niccoli et al., 2009; Galiuto et al., 2010) 
In addition to guide and evaluate treatment, an ongoing study evaluates the effect of 
ultrasound contrast enhanced thrombolysis in acute treatment of STEMI. The ongoing 
Sonolysis trial uses a combination of ultrasound induced contrast microbubbles destruction 
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at high mechanical index ultrasound and thrombolysis, where destruction of microbubbles 
causes streaming and thereby improves the effect of thrombolysis in reopening of the infarct 
related artery (Slikkerveer et al., 2008).  
 
 
Fig. 8. Complications in acute myocardial infarction. Myocardial mural thrombus in the 
apex of the left ventricle, with lack of contrast enhancement due to the thrombus avascular 
characteristics (Panel A and B). In comparison, the typical contrast enhancement in a patient 
with pulmonary carcinoma and a myocardial metastasis in the right ventricle (Panel C).  
Development of intraventricular mural thrombus is a feared complication to acute 
myocardial infarction which untreated may lead to severe thromboembolic episodes. A 
magnetic resonance study demonstrated that mural thrombus formation in patients with 
acute coronary syndromes may be more common than previously anticipated (Solheim et 
al., 2010). However, suspected mural thrombus may be ruled out in about 90% of patients 
by contrast echocardiography (Kurt et al., 2009; Hamilton-Craige et al., 2010). Diagnosing a 
mural thrombus with contrast echocardiography is simple and can be performed with a 
single ultrasound contrast bolus injection. A mural thrombus is characterized by a lack of 
contrast enhancement due to its avascular nature (Fig 8 Panel A and B). In contrast, a 
myocardial tumor is characterized by contrast enhancement which is particular high in 
malignant tumores that are highly vascularised structures (Fig.8 panel C).  
In acute myocardial infarction, myocardial rupture is a rare and deadly complication. A 
rupture of the free ventricular wall is usually associated with sudden death, but 
occasionally, epicardial coverage occurs and subsequent formation of a ventricular 
pseudoaneurysm. Ventricular pseudoaneurysms can be difficult to diagnose by 
conventional echocardiography (Fig. 9 left panel), but are easy to recognize after injection of 
an ultrasound contrast agent during imaging (Fig. 9 right panel).  
3.3 Restenosis after revascularization 
In patients undergoing percutaneous coronary intervention with stent implantation, 10-30% 
will develop significant angiographic restenosis in spite of initial successful treatment. 
Restenosis is caused by intimal hyperplasia and is asymptomatic in 50% of patients (Giedd 
& Bergmann., 2004). However, even in asymptomatic patients development of restenosis is 
associated with a poorer prognosis (Pfisterer et al., 1993; Zellweger et al., 2003). Non- 
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Fig. 9. Extracardial contrast enhancement due to a pseudoaneurysm in the lateral wall of the 
left ventricle (right panel) not visible with conventional echocardiography (left panel). 
invasive diagnosis of restenosis can be challenging. Previous SPECT studies have 
demonstrated that normalization of regional myocardial perfusion usually occurs after 
successful revascularization (Manyari et al., 1988; Zhang et al., 2004). In a follow-up study 
using quantitative contrast stress echocardiography in 33 patients with stable angina 
pectoris treated with percutaneous coronary intervention and stent implantation, there was 
no improvement in stress-induced myocardial perfusion during follow-up in patients who 
had developed a significant angiographic restenosis, while the stress-induced perfusion was 
improved in patients with successful revascularisation at 9 months (Lønnebakken et al., 
2009).  
At present, quantitative contrast stress echocardiography is not recommended in routine 
assessment of coronary artery disease due to inter-individual variation and lack of data on 
normal values and cut-off values indicating ischemia for this method. Still, serial assessment 
in individual patients may be useful. 
3.4 Non-obstructive coronary artery disease  
Although coronary angiography remains the gold standard for diagnosis of coronary artery 
disease, it should be kept in mind that myocardial ischemia may be present in spite of 
angiographically open epicardial coronary arteries, a condition known as non-obstructive 
ischemic heart disease. This condition cannot be diagnosed using angiography alone, but 
requires additional use of perfusion assessment with cardiac magnetic resonance or MCE.  
In patients with acute coronary syndrome, non-obstructive ischemic heart disease is present 
in 15% of women and 9% of men (Berger et al., 2009). Cardiac magnetic resonance studies in 
NSTEMI patients have demonstrated myocardial infarction in up to 34% of patients with 
normal coronary arteries by coronary angiography.  Clot autolysis and recanalisation of the 
infarct related artery are the main reasons for this finding as well as microvascular disease 
that can not be detected by coronary angiography, the current diagnostic gold standard.  In 
patients with recurrent hospitalisation for chest pain and “normal” coronary arteries by 
coronary angiography additional non-invasive cardiac imaging should be performed. MCE 
www.intechopen.com
Coronary Angiography 
 – Advances in Noninvasive Imaging Approach for Evaluation of Coronary Artery Disease 
 
74
can be used to diagnose myocardial ischemia in such patients and thereby distinguish 
between patients with non-cardiac chest pain and patients with non-obstructive ischemic 
heart disease. Non-obstructive ischemic heart disease most often is caused by microvascular 
disease associated with diabetes mellitus, obesity and hypertension, but also hemodynamic 
changes like increased left ventricular filling pressure and increased arterial stiffness can 
cause reduced myocardial perfusion pressure and hence myocardial ischemia despite 
angiographically normal epicardial coronary arteries (London et al., 2004).  Chronic 
myocardial ischemia in such patients may promote development of myocardial fibrosis and 
secondary structural changes in the left ventricle, finally leading to functional impairment 
and heart failure (Niccoli et al., 2009).   
Another recently recognized condition mainly affecting women is the Takotsubo 
cardiomyopathy, mimicking an acute myocardial infarction. The exact pathophysiological 
mechanism remains unknown in Takotsubo cardiomyopathy, but it involves myocardial 
hypoperfusion that can be diagnosed by contrast echocardiography causing functional 
impairment mainly in the apical part of the left ventricle with the characteristic apical 
ballooning (Fig. 10) (Abdelmoneim et al., 2009). The microvascular involvement is also 
confirmed by early cardiac MRI demonstrating late gadolinium uptake suggesting diffuse 
microcirculation damage (Avegliano et al., 2011).  
 
 
Fig. 10. Takotsubo Cardiomyopathy. Contrast echocardiography in diastole and systole 
illustrating the apical akinesia and ballooning of the left ventricle in an apical 4-chamber 
view, in addition there is a delayed contrast enhancement in the apical segments of the left 
ventricle. The right panel shows the normal coronary angiogram confirming the diagnosis 
Takotsubo cardiomyopathy. 
4. Conclusion 
Contrast echocardiography allows simultaneous assessment of regional myocardial function 
and perfusion, improving non-invasive diagnosis and assessment of coronary artery 
disease. Contrast echocardiography gives information on the physiological impact of the 
coronary artery stenosis, reveals the ischemic burden, detects viable myocardium and may 
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act as a supplemental tool to coronary angiography in management of coronary artery 
disease and in follow-up after treatment. In addition, the ability to diagnose myocardial 
ischemia in patients with no-reflow phenomenon or microvascular disease and 
angiographically normal coronary arteries may help distinguishing patients with non-
obstructive ischemic coronary artery disease from patients with non-cardiac chest pain. 
Future studies using targeted contrast microbubbles against specific disease processes may 
further improve diagnosis in ischemic coronary artery disease, and on-going studies explore 
the use of ultrasound contrast agents to potentiate the effect of thrombolysis in acute 
coronary artery occlusions.  
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